Added big yesterday and will continue to add on strength
Bullish
P
Here we go again!
Bullish
P
Why huge volume and price up? Any news?
Bullish
R
Any news ? High volume
Neutral
J
Rumor has it we have a buyout offer?
Bullish
S
Bullish
S
any news on this, guys?
L
An interesting insight into Q1 for $CHPI
It shouldn’t come as a surprise that they have not excelled during COVID-19, though we can argue it shouldn’t have been hit so hard in losses being in the pharma industry. The CEO states this is partially due to the Chinese New Year slowing down production also.
Whilst it’s not showing the boom I was hoping for, we may still see a bump from some much needed press release. If we can see this jump up beyond .50 breaking line, we will have made sufficient progress, imho.
China Pharma Holdings (CPHI) Stock: Here’s Why It’s Flying! The company has several drugs on the Chinese market that are designed to treat the same types of symptoms that patients dealing with the coronavirus are experiencing. As such, the company’s already approved treatments may lead to the company being able to treat the condition.
Moreover, CPHI currently owns the only bio manufacturing facility near the epicenter of the outbreak in China. So, not only does the company have drugs that may treat coronavirus, it has the facility and ability to make the treatments and get them to the targeted patient population very quickly.
As investors start to realize the strategic advantage that the company has when it comes to the treatment of the coronavirus, we’re starting to see strong upward movement.
China Pharma Holdings, Inc. (NYSEAMERICAN: CPHI) is rocketing this morning, trading on gains of more than 50% early on. If you go digging for news, you’re not going to find any, but there is a good reason for the run. It seems as though the coronavir
China Pharma Holdings, Inc. (NYSEAMERICAN: CPHI) is rocketing this morning, trading on gains of more than 50% early on. If you go digging for news, you’re not going to find any, but there is a good reason for the run. It seems as though the coronavir
alphastocknews.com
E
Â
Home
Biotech
Cannabis
Basic Materials
Consumer Goods
Tech
Tips, Tricks & Facts

Home  Biotech Stock News
Biotech Stock News
China Pharma Holdings (CPHI) Stock: Here’s Why It’s Flying!
By
 Joshua Rodriguez
 -
February 3, 2020
0

China Pharma Holdings, Inc. (NYSEAMERICAN: CPHI) is rocketing this morning, trading on gains of more than 50% early on. If you go digging for news, you’re not going to find any, but there is a good reason for the run. It seems as though the coronavirus has triggered a short squeeze. Here’s what’s going on. Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
Why CPHI Stock Is Soaring
After seeing that no press releases or SEC filings came out of China Pharma Holdings this morning, I took to social media to see if I could find the catalyst that started the short squeeze. What I found is what I believe to be a clear reason for the run. All over StockTwits and other investing-related social media platforms, I’m seeing posts surrounding the strategic positioning of the company in the midst of a deadly outbreak. Ultimately, the new virus known as coronavirus is spreading through China and has found its way to different areas around the world. While there are no approved products that are designed to treat coronavirus, the virus is an upper respiratory viral infection. This is where the strategic positioning of CPHI comes in.
The company has several drugs on the Chinese market that are designed to treat the same types of symptoms that patients dealing with the coronavirus are experiencing. As such, the company’s already approved treatments may lead to the company being able to treat the condition. Moreover, CPHI currently owns the only bio manufacturing facility near the epicenter of the outbreak in China. So, not only does the company have drugs that may treat coronavirus, it has the facility and ability to make the treatments and get them to the targeted patient population very quickly. As investors start to realize the strategic advantage that the company has when it comes to the treatment of the coronavirus, we’re starting to see strong upward movement. In fact, before today, CPHI was a pretty heavily shorted stock. Considering the upward movement, those with short positions are losing money quickly. This generally leads to short sellers racing to buy shares in an attempt to cover their positions and cut the bleeding. All in all, this is what a short squeeze is made of.
What’s Next?
Really, there’s no telling what’s in store for China Pharma Holdings. There’s no doubt that we’re likely to see some profit taking when investors feel the time is right, but after that, this may be a huge opportunity. After all, if CPHI does indeed announce that it is working to treat the coronavirus, given its strategic advantages, the stock could soar as the treatment could quickly become a blockbuster. At the end of the day, only time will tell what happens next, but the stock seems like a pretty strong bet! Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
Don’t Miss The Next Big Story!
Join our free mailing list below to receive real-time news alerts!
Subscribe Today!
*Â indicates required
Email Address *
First Name
TAGS
Biotech Stock News
CPHI
Penny Stocks
Previous articleInsmed (INSM) Stock Rockets On Trial Results
Next articleVaxart (VXRT) Stock Continues Skyward On Coronavirus Program

Joshua Rodriguez
Hi, Im' Joshua Rodriguez. I'm the founder of Alpha Stock News and CNA Finance. I'm also one of the brains behind iWatch Markets and am often published on websites like Benzinga, US News & World Report, Yahoo! Finance, and several others. To get in touch, contact me through my Contact Page.
RELATED ARTICLESMORE FROM AUTHOR

Vaxart (VXRT) Stock Continues Skyward On Coronavirus Program

Insmed (INSM) Stock Rockets On Trial Results

Chesapeake Energy (CHK) Stock Heads Up On Production News
LEAVE A REPLY
Save my name, email, and website in this browser for the next time I comment. Â Notify me of follow-up comments by email. Â Notify me of new posts by email.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Get FREE Actionable Updates!

Latest News

Vaxart (VXRT) Stock Continues Skyward On Coronavirus Program
Joshua Rodriguez - February 3, 2020
0
Vaxart Inc (NASDAQ: VXRT) is having yet another strong day in the market today, following up on the gains that we saw from the...

China Pharma Holdings (CPHI) Stock: Here’s Why It’s Flying!
February 3, 2020

Insmed (INSM) Stock Rockets On Trial Results
February 3, 2020
Alpha Stock News is not an investment advisor or broker/dealer. The articles published on this website are designed for information and entertainment purposes only. Before making any investment decisions, it is important to do your due diligence and consider speaking with an investing professional.
Is there any truth to the story that CPHI might be collaborating with Sinopharm on a covid vaccine development in China? Any news of this laboratory development?
Bullish
k
Very likely the company has returned back to profitable, with the additional revenues from selling the sanitizers.
Bullish
S
short covering will push the price much much higher. No shares available for sale. That is why big gap between bid and ask.
Bullish
k
People have started to realize how important the Chinese medicines are in treating the coronavirus patients. Go CPHI, to the moon.
It shouldn’t come as a surprise that they have not excelled during COVID-19, though we can argue it shouldn’t have been hit so hard in losses being in the pharma industry. The CEO states this is partially due to the Chinese New Year slowing down production also.
Whilst it’s not showing the boom I was hoping for, we may still see a bump from some much needed press release. If we can see this jump up beyond .50 breaking line, we will have made sufficient progress, imho.
Source: https://finance.yahoo.com/amphtml/news/china-pharma-holdings-inc-reports-103000126.html
The company has several drugs on the Chinese market that are designed to treat the same types of symptoms that patients dealing with the coronavirus are experiencing. As such, the company’s already approved treatments may lead to the company being able to treat the condition.
Moreover, CPHI currently owns the only bio manufacturing facility near the epicenter of the outbreak in China. So, not only does the company have drugs that may treat coronavirus, it has the facility and ability to make the treatments and get them to the targeted patient population very quickly.
As investors start to realize the strategic advantage that the company has when it comes to the treatment of the coronavirus, we’re starting to see strong upward movement.
https://alphastocknews.com/china-pharma-holdings-cphi-stock-heres-why-its-flying/2547/
Home
Biotech
Cannabis
Basic Materials
Consumer Goods
Tech
Tips, Tricks & Facts

Home  Biotech Stock News
Biotech Stock News
China Pharma Holdings (CPHI) Stock: Here’s Why It’s Flying!
By
 Joshua Rodriguez
 -
February 3, 2020
0

China Pharma Holdings, Inc. (NYSEAMERICAN: CPHI) is rocketing this morning, trading on gains of more than 50% early on. If you go digging for news, you’re not going to find any, but there is a good reason for the run. It seems as though the coronavirus has triggered a short squeeze. Here’s what’s going on.
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
Why CPHI Stock Is Soaring
After seeing that no press releases or SEC filings came out of China Pharma Holdings this morning, I took to social media to see if I could find the catalyst that started the short squeeze. What I found is what I believe to be a clear reason for the run.
All over StockTwits and other investing-related social media platforms, I’m seeing posts surrounding the strategic positioning of the company in the midst of a deadly outbreak. Ultimately, the new virus known as coronavirus is spreading through China and has found its way to different areas around the world.
While there are no approved products that are designed to treat coronavirus, the virus is an upper respiratory viral infection. This is where the strategic positioning of CPHI comes in.
The company has several drugs on the Chinese market that are designed to treat the same types of symptoms that patients dealing with the coronavirus are experiencing. As such, the company’s already approved treatments may lead to the company being able to treat the condition.
Moreover, CPHI currently owns the only bio manufacturing facility near the epicenter of the outbreak in China. So, not only does the company have drugs that may treat coronavirus, it has the facility and ability to make the treatments and get them to the targeted patient population very quickly.
As investors start to realize the strategic advantage that the company has when it comes to the treatment of the coronavirus, we’re starting to see strong upward movement.
In fact, before today, CPHI was a pretty heavily shorted stock. Considering the upward movement, those with short positions are losing money quickly. This generally leads to short sellers racing to buy shares in an attempt to cover their positions and cut the bleeding. All in all, this is what a short squeeze is made of.
What’s Next?
Really, there’s no telling what’s in store for China Pharma Holdings. There’s no doubt that we’re likely to see some profit taking when investors feel the time is right, but after that, this may be a huge opportunity.
After all, if CPHI does indeed announce that it is working to treat the coronavirus, given its strategic advantages, the stock could soar as the treatment could quickly become a blockbuster. At the end of the day, only time will tell what happens next, but the stock seems like a pretty strong bet!
Stop wasting your time! Start finding winning trades in minutes with Trade Ideas!
Don’t Miss The Next Big Story!
Join our free mailing list below to receive real-time news alerts!
Subscribe Today!
*Â indicates required
Email Address *
First Name
TAGS
Biotech Stock News
CPHI
Penny Stocks
Previous articleInsmed (INSM) Stock Rockets On Trial Results
Next articleVaxart (VXRT) Stock Continues Skyward On Coronavirus Program

Joshua Rodriguez
Hi, Im' Joshua Rodriguez. I'm the founder of Alpha Stock News and CNA Finance. I'm also one of the brains behind iWatch Markets and am often published on websites like Benzinga, US News & World Report, Yahoo! Finance, and several others. To get in touch, contact me through my Contact Page.
RELATED ARTICLESMORE FROM AUTHOR

Vaxart (VXRT) Stock Continues Skyward On Coronavirus Program

Insmed (INSM) Stock Rockets On Trial Results

Chesapeake Energy (CHK) Stock Heads Up On Production News
LEAVE A REPLY
Save my name, email, and website in this browser for the next time I comment.
 Notify me of follow-up comments by email.
 Notify me of new posts by email.
This site uses Akismet to reduce spam. Learn how your comment data is processed.
Get FREE Actionable Updates!

Latest News

Vaxart (VXRT) Stock Continues Skyward On Coronavirus Program
Joshua Rodriguez - February 3, 2020
0
Vaxart Inc (NASDAQ: VXRT) is having yet another strong day in the market today, following up on the gains that we saw from the...

China Pharma Holdings (CPHI) Stock: Here’s Why It’s Flying!
February 3, 2020

Insmed (INSM) Stock Rockets On Trial Results
February 3, 2020
Alpha Stock News is not an investment advisor or broker/dealer. The articles published on this website are designed for information and entertainment purposes only. Before making any investment decisions, it is important to do your due diligence and consider speaking with an investing professional.
© Alpha Stock News 2019